Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
The COVID−19 pandemic not only resulted in a global crisis, but also accelerated vaccine development and antibody discovery. Herein we report a synthetic humanized VHH library development pipeline for nanomolar-range affinity VHH binders to SARS-CoV-2 variants of concern (VoC) receptor binding domai...
Main Authors: | Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, Alexander Meleshko, Sergei Semyonov |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.965446/full |
Similar Items
-
CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01) -
Nanobodies that Neutralize HIV
by: Robin A. Weiss, et al.
Published: (2019-07-01) -
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
by: Dmitri Dormeshkin, et al.
Published: (2023-05-01) -
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
by: Qizhong Lu, et al.
Published: (2021-01-01) -
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
by: Maxwell A. Stefan, et al.
Published: (2021-01-01)